|
US11120889B2
(en)
*
|
2012-05-09 |
2021-09-14 |
Georgia Tech Research Corporation |
Method for synthesizing a nuclease with reduced off-site cleavage
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
EP3875603A1
(en)
*
|
2016-07-12 |
2021-09-08 |
Life Technologies Corporation |
Compositions and methods for detecting nucleic acid regions
|
|
CN118530967A
(zh)
|
2017-08-23 |
2024-08-23 |
通用医疗公司 |
具有改变的PAM特异性的工程化的CRISPR-Cas9核酸酶
|
|
CN107723358B
(zh)
*
|
2017-10-26 |
2021-03-19 |
国家卫生健康委科学技术研究所 |
苯丙酮尿症检测试剂盒
|
|
CN112533627A
(zh)
*
|
2018-03-27 |
2021-03-19 |
G+Flas 生命科学公司 |
序列特异性体内细胞靶向
|
|
WO2020012335A1
(en)
*
|
2018-07-10 |
2020-01-16 |
Alia Therapeutics S.R.L. |
Vesicles for traceless delivery of guide rna molecules and/or guide rna molecule/rna-guided nuclease complex(es) and a production method thereof
|
|
CN113286880A
(zh)
|
2018-08-28 |
2021-08-20 |
旗舰先锋创新Vi有限责任公司 |
调控基因组的方法和组合物
|
|
US20200268906A1
(en)
*
|
2018-10-18 |
2020-08-27 |
Intellia Therapeutics, Inc. |
Nucleic acid constructs and methods of use
|
|
JP7657726B2
(ja)
|
2019-03-19 |
2025-04-07 |
ザ ブロード インスティテュート，インコーポレーテッド |
編集ヌクレオチド配列を編集するための方法および組成物
|
|
WO2021016075A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
EP4034659A4
(en)
|
2019-09-27 |
2024-10-16 |
The Broad Institute, Inc. |
PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
|
|
CA3162499A1
(en)
|
2019-11-22 |
2021-05-27 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
EP4085141A4
(en)
|
2019-12-30 |
2024-03-06 |
The Broad Institute, Inc. |
GENOME EDITING USING REVERSE TRANSCRIPTASE FOR FULLY ACTIVE CRISPR COMPLEXES
|
|
IL296024A
(en)
|
2020-03-04 |
2022-10-01 |
Flagship Pioneering Innovations Vi Llc |
Methods and compositions for modulating a genome
|
|
US20230348939A1
(en)
|
2020-03-04 |
2023-11-02 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
JP2023516692A
(ja)
|
2020-03-04 |
2023-04-20 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
ゲノムを調節するための方法及び組成物
|
|
CA3174483A1
(en)
|
2020-03-04 |
2021-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Improved methods and compositions for modulating a genome
|
|
AU2021232069A1
(en)
|
2020-03-05 |
2022-11-03 |
Flagship Pioneering Innovations Vi, Llc |
Host defense suppressing methods and compositions for modulating a genome
|
|
DE112021002672T5
(de)
|
2020-05-08 |
2023-04-13 |
President And Fellows Of Harvard College |
Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
|
|
TW202208632A
(zh)
*
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
WO2021248102A1
(en)
|
2020-06-05 |
2021-12-09 |
Flagship Pioneering Innovations Vi, Llc |
Template guide rna molecules
|
|
EP4274894A2
(en)
|
2021-01-11 |
2023-11-15 |
The Broad Institute, Inc. |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
US20240132916A1
(en)
|
2021-02-09 |
2024-04-25 |
The Broad Institute, Inc. |
Nuclease-guided non-ltr retrotransposons and uses thereof
|
|
US20240042058A1
(en)
|
2021-02-26 |
2024-02-08 |
Flagship Pioneering Innovations Vi, Llc |
Tissue-specific methods and compositions for modulating a genome
|
|
CA3214277A1
(en)
|
2021-03-19 |
2022-09-22 |
Flagship Pioneering Innovations Vi, Llc |
Ltr transposon compositions and methods
|
|
EP4314257A4
(en)
|
2021-04-01 |
2025-07-09 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
|
|
WO2022251356A1
(en)
|
2021-05-26 |
2022-12-01 |
Flagship Pioneering Innovations Vi, Llc |
Integrase compositions and methods
|
|
EP4352230A4
(en)
|
2021-06-03 |
2025-06-11 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treating Wilson's disease
|
|
WO2023283092A1
(en)
|
2021-07-06 |
2023-01-12 |
Prime Medicine, Inc. |
Compositions and methods for efficient genome editing
|
|
EP4373939A4
(en)
|
2021-07-23 |
2025-11-19 |
Prime Medicine Inc |
Genome editing compositions and treatment methods for chronic granulomatous disease
|
|
WO2023015318A2
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of cystic fibrosis
|
|
WO2023015309A2
(en)
|
2021-08-06 |
2023-02-09 |
The Broad Institute, Inc. |
Improved prime editors and methods of use
|
|
JP2024533311A
(ja)
|
2021-09-08 |
2024-09-12 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
ゲノムを調節するための方法及び組成物
|
|
CA3231594A1
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Serpina-modulating compositions and methods
|
|
MX2024002930A
(es)
|
2021-09-08 |
2024-05-29 |
Flagship Pioneering Innovations Vi Llc |
Metodos y composiciones para modular un genoma.
|
|
KR20240099164A
(ko)
|
2021-09-08 |
2024-06-28 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
Pah-조절 조성물 및 방법
|
|
AU2022342169A1
(en)
|
2021-09-08 |
2024-03-28 |
Flagship Pioneering Innovations Vi, Llc |
Hbb-modulating compositions and methods
|
|
WO2023070062A2
(en)
|
2021-10-21 |
2023-04-27 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of usher syndrome type 3
|
|
US20250011766A1
(en)
|
2021-11-09 |
2025-01-09 |
Prime Medicine, Inc. |
Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
|
|
EP4430185A1
(en)
|
2021-11-09 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
|
|
EP4430189A1
(en)
|
2021-11-11 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fragile x syndrome
|
|
EP4437106A2
(en)
|
2021-11-24 |
2024-10-02 |
Prime Medicine, Inc. |
Methods and compositions for inhibiting mismatch repair
|
|
JP2024545947A
(ja)
|
2021-11-24 |
2024-12-16 |
プライム メディシン， インコーポレイテッド |
修飾されたプライム編集ガイドｒｎａ
|
|
EP4444362A4
(en)
|
2021-12-10 |
2026-04-01 |
Flagship Pioneering Innovations Vi Llc |
CFTR COMPOSITIONS AND MODULATION METHODS
|
|
EP4504921A4
(en)
|
2022-04-01 |
2026-04-15 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTID SEQUENCES
|